Michaelides Stefanos, Hartmann Viktoria, Nüssler Volkmar, Zielinski Christoph, von Bergwelt-Baildon Michael, Kobold Sebastian
Division of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany.
Tumorzentrum München, Munich, Germany.
Hum Vaccin Immunother. 2025 Dec;21(1):2532967. doi: 10.1080/21645515.2025.2532967. Epub 2025 Jul 18.
The Immunotherapy of Cancer (ITOC) meeting is an international conference providing a platform for immuno-oncologists worldwide to present and discuss their research and newest findings. Being held in Munich annually, the 11th edition took place in April 2025 and saw broad discussions about new concepts in the field of immuno-oncology, mixed with exciting clinical results but also with a glimpse back into the past. This was mirrored by the lifetime achievement award, given to for his groundbreaking work on the immune surveillance of cancer. ITOC11 impressively showcase how far immuno-oncology has come in a conference extending from the discipline's very beginnings up to some of the most exciting new findings in the field of cancer immunology. The conference has demonstrated that tumor immunology is not only about cancer and immune cells, but extends far beyond.
癌症免疫治疗(ITOC)会议是一个国际会议,为全球免疫肿瘤学家提供了一个展示和讨论他们的研究及最新发现的平台。该会议每年在慕尼黑举行,第11届会议于2025年4月召开,会上广泛讨论了免疫肿瘤学领域的新概念,既有令人振奋的临床结果,也回顾了过去。这一点在终身成就奖中得到了体现,该奖项授予了因在癌症免疫监视方面的开创性工作的[具体人物未提及]。ITOC11令人印象深刻地展示了免疫肿瘤学从该学科的最初阶段发展到癌症免疫学领域一些最令人兴奋的新发现的历程。该会议表明,肿瘤免疫学不仅关乎癌症和免疫细胞,而且其范畴远不止于此。